ACO Name and Location

Privia Quality Network, LLC
950 N Glebe Rd
Suite 700
Arlington, VA 22203

ACO Primary Contact

Mark Lamm
Phone: 571-366-8850
Email: mark.lamm@priviahealth.com

Organizational Information

ACO Participants:

ACO Participants ACO Participant in Joint Venture
Accessible Physician Home Care, LLC N
Allergy And Asthma Clinic Of Maryland N
Anchor Healthcare PLC N
Anju Verma MD PC N
Bay West Endocrinology Associates PA N
Best Health Services PC N
Christina Braun MD PC N
Comprehensive Neurology And Sleep Medicine, P.A. N
Denise Chevalier Hamilton N
Dr. Helbing Allergy & Asthma Associates LTD N
Felice Physical Therapy N
Forsyth Medical Group, LLC N
Fredericksburg Primary Care, P.C. N
Healthcare For Women PC N
Inpatient Surgical Consultants PA N
Lawrence Miller N
Matthews Internal Medicine PLLC N
Metro Orthopedics & Sports Therapy N
Mount Vernon Internal Medicine N
Nephrology & Hypertension Of Virginia, PLLC N
New Hope Family Medicine PA N
Newbridge Spine And Pain Center LLC N
Next Journey Orthopaedics PLLC N
Northern Virginia Gastroenterology, PC N
Northern Virginia Physicians To Women, LTD. N
Ortho OIC Orthopaedic Immediate Care LLC N
Premier Internal Medicine & Urgent Care, P.L.L.C. N
Primedocs PC N
Prismamed Services LLC N
Privia Medical Group LLC N
Randleman Medical Center N
Randolph Pulmonary & Sleep Clinic, PLLC N
Richard A. Dougherty, MD, PA N
Telegraph Corner Family Medicine PC N
VCM Family Medicine N
Virginia Womens Center INC N
William D. Hunter, MD PA N

ACO Governing Body:

Member First Name Member Last Name Member Title/Position Member’s Voting Power – Expressed as a percentage Membership Type ACO Participant Legal Business Name, if Applicable ACO Participant DBA, if applicable
Keith Berkle Chairman 10% ACO Participant Privia Medical Group LLC N/A
Jane Belford Director 10% Beneficiary Representative    
Stephanie Carter Director 10% ACO Participant Privia Medical Group LLC N/A
Corey Perdue Director 10% Other Privia Medical Group LLC N/A
Habib Chotani Director 10% ACO Participant Privia Medical Group LLC N/A
Thomas Eppes Director 10% ACO Participant Privia Medical Group LLC N/A
Ann Marie Gordon Director 10% ACO Participant Privia Medical Group LLC N/A
Catie Zaner Director 10% ACO Participant Privia Medical Group LLC N/A
David West Director 10% ACO Participant Privia Medical Group LLC N/A
Linda Powers Director 10% ACO Participant Privia Medical Group LLC N/A

Key ACO Clinical and Administrative Leadership:

ACO Executive: Corey Perdue
Medical Director: Jarrett Dodd, MD
Compliance Officer: Stephanie Clark
Quality Assurance/Improvement Officer: David West

Associated Committees and Committee Leadership:

Committee Name Committee Leader Name and Position
Clinical IT Committee Jarret Dodd, Chair
Clinical Performance Committee David West, Chair
Compliance Committee Caroline Huang, Chair
Credentialing Committee Habib Chotani, Chair
Finance Committee Sumi Sexton, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangements
  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Third Agreement Period
    • Performance Year 2024: $56,874,293
    • Performance Year 2023: $51,566,511
    • Performance Year 2022: $44,130,899
    • Performance Year 2021: $41,642,012
    • Performance Year 2020: $42,266,717
  • Second Agreement Period
    • Performance Year 2019: $16,998,165
    • Performance Year 2018: $20,066,830
    • Performance Year 2017: $18,079,932
  • First Agreement Period
    • Performance Year 2016: $0
    • Performance Year 2015: $6,156,225
    • Performance Year 2014: $2,793,592

Shared Savings Distribution

  • Third Agreement Period
    • Performance Year 2024
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2023
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2022
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2021
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2020
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
  • Second Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2018
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2017
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2015
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2014
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%

Quality Performance Results

2024 Quality Performance Results:

Quality Performance Results are based on CMS Web Interface Measure Set

Measure # Measure Name Collection Type Reported Performance Rate Current Year Mean Performance Rate (SSP ACO’s)
Measure # 001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) CMS Web Interface 4.42 9.44
Measure # 134 Preventative Care and Screening: Screening for Depression and Follow-up Plan CMS Web Interface 86.37 81.46
Measure # 236 Controlling High Blood Pressure CMS Web Interface 85.10 79.49
Measure # 318 Falls: Screening for Future Fall Risk CMS Web Interface 93.06 88.99
Measure # 110 Preventative Care and Screening: Influenza Immunization CMS Web Interface 83.80 68.60
Measure # 226 Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention CMS Web Interface 100.00 79.98
Measure # 113 Colorectal Cancer Screening CMS Web Interface 85.45 77.81
Measure # 112 Breast Cancer Screening CMS Web Interface 77.80 80.93
Measure # 438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease CMS Web Interface 83.33 86.50
Measure # 370 Depression Remission at Twelve Months CMS Web Interface 30.67 17.35
Measure # 321 CAHPS for MIPS CMS Web Interface 4.62 6.67
Measure # 479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups CMS Web Interface 0.1457 0.1517
Measure # 484 Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions CMS Web Interface — 37.00
CAHPS-1 Getting Timely Care, Appointments, and Information CAHPS for MIPS Survey 82.68 83.70
CAHPS-2 How Well Providers Communicate CAHPS for MIPS Survey 92.71 93.96
CAHPS-3 Patient’s Rating of Provider CAHPS for MIPS Survey 91.53 92.43
CAHPS-4 Access to Specialists CAHPS for MIPS Survey 70.43 75.76
CAHPS-5 Health Promotion and Education CAHPS for MIPS Survey 67.25 65.48
CAHPS-6 Shared Decision Making CAHPS for MIPS Survey 59.71 62.31
CAHPS-7 Health Status and Functional Status CAHPS for MIPS Survey 74.85 74.14
CAHPS-8 Care Coordination CAHPS for MIPS Survey 84.43 85.89
CAHPS-9 Courteous and Helpful Office Staff CAHPS for MIPS Survey 91.73 92.89
CAHPS-11 Stewardship of Patient Resources CAHPS for MIPS Survey 22.19 26.98
  • *For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance.
  • *For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs’ providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov